Advanced search
Publication Cover
Statistics in Biopharmaceutical Research Volume 15, 2023 - Issue 3
Submit an article Journal homepage
440
Views
0
CrossRef citations to date
0
Altmetric
Statistical Innovation in Healthcare: Celebrating the Past 40 Years and Looking Toward the Future - Special issue for the 2021 Regulatory-Industry Statistics Workshop

The Use of Machine Learning in Regulatory Drug Safety Evaluation

Di ZhangDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MDCorrespondence[email protected]
,
Jaejoon SongDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
,
Sai DharmarajanDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
,
Tae Hyun JungDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
,
Hana LeeDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
,
Yong MaDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
,
Rongmei ZhangDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MDCorrespondence[email protected]
&
Mark LevensonDivision of Biometrics VII, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
 show all
Pages 519-523 | Received 20 Dec 2021, Accepted 21 Jul 2022, Published online: 23 Sep 2022

References

  • Ball, R., Robb, M., Anderson, S. A., and Dal Pan, G. (2016), “The FDA’s Sentinel initiative—A Comprehensive Approach to Medical Product Surveillance,” Clinical Pharmacology and Therapeutics, 99, 265–268. DOI: 10.1002/cpt.320.
  • Barber, E. L., Garg, R., Persenaire, C., and Simon, M. (2021), “Natural Language Processing with Machine Learning to Predict Outcomes after Ovarian Cancer Surgery,” Gynecologic Oncology, 160, 182–186. DOI: 10.1016/j.ygyno.2020.10.004.
  • Beam, A. L., and Kohane, I. S. (2018), “Big Data and Machine Learning in Health Care,” JAMA, 319, 1317–1318. DOI: 10.1001/jama.2017.18391.
  • Beam, A. L., Manrai, A. K., and Ghassemi, M. (2020), “Challenges to the Reproducibility of Machine Learning Models in Health Care,” JAMA, 323, 305–306. DOI: 10.1001/jama.2019.20866.
  • Bhandari, A. (2020), ‘Feature Scaling for Machine Learning: Understanding the Difference between Normalization vs. Standardization,” Analytics Vidhya. https://www.analyticsvidhya.com/blog/2020/04/feature-scaling-machine-learning-normalization-standardization/
  • Breiman, L. (2001), “Statistical Modeling: The Two Cultures,” (with comments and a rejoinder by the author), Statistical Science, 16, 199–231.
  • Bzdok, D., Altman, N., and Krzywinski, M. (2018), “Statistics Versus Machine Learning,” Nature Methods, 15, 233–234. DOI: 10.1038/nmeth.4642.
  • Carey, M., Wu, S., Gan, G., and Wu, H. (2016), “Correlation-based Iterative Clustering Methods for Time Course Data: The Identification of Temporal Gene Response Modules for Influenza Infection in Humans,” Infectious Disease Modelling, 1, 28–39. DOI: 10.1016/j.idm.2016.07.001.
  • Carrell, D. S., Gruber, S., Floyd, J. S., Bann, M., Cushing-Haugen, K., Johnson, R., Graham, V., Cronkite, D., Hazlehurst, B., Felcher, A. H., and Bejin, C. A. (2021), “Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning,” Pharmacoepidemiology and Drug Safety, 30, 16–17.
  • CDER, F. (2018), “Questions and Answers on FDA’s Adverse Event Reporting System (FAERS).” Available at https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers.
  • Chakravarty, A. G., Izem, R., Keeton, S., Kim, C. Y., Levenson, M. S., and Soukup, M. (2016), “The Role of Quantitative Safety Evaluation in Regulatory Decision Making of Drugs,” Journal of Biopharmaceutical Statistics, 26, 17–29. DOI: 10.1080/10543406.2015.1092026.
  • Chowdhury, G. G. (2003), “Natural Language Processing,” Annual Review of Information Science and Technology, 37, 51–89. DOI: 10.1002/aris.1440370103.
  • Clair, C. O. S., Golub, N. I., Ma, Y., Song, J., Winiecki, S. K., and Menschik, D. L. (2020), “Characteristics Associated with us Outpatient Opioid Analgesic Prescribing and Gabapentinoid Co-prescribing,” American Journal of Preventive Medicine, 58, e11–e19. DOI: 10.1016/j.amepre.2019.08.029.
  • Collins, G. S., and Moons, K. G. (2019), “Reporting of Artificial Intelligence Prediction Models,” The Lancet, 393, 1577–1579. DOI: 10.1016/S0140-6736(19)30037-6.
  • Commissioner. (2016), “21st Century Cures Act.” Available at https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act.
  • Cunningham, P., Cord, M., and Delany, S. J. (2008), “Supervised Learning,” in Machine Learning Techniques for Multimedia, eds. M. Cord and P. Cunningham, pp. 21–49, Berlin: Springer.
  • Desai, R. J., Matheny, M. E., Johnson, K., Marsolo, K., Curtis, L. H., Nelson, J. C., Heagerty, P. J., Maro, J., Brown, J., Toh, S., Nguyen, M., Ball, R., Pan, G. D., Wang, S. V., Gagne, J. J., and Schneeweiss, S. (2021), “Broadening the Reach of the FDA Sentinel System: A Roadmap for Integrating Electronic Health Record Data in a Causal Analysis Framework,” NPJ Digital Medicine, 4, 1–6. DOI: 10.1038/s41746-021-00542-0.
  • Dorie, V., Hill, J., Shalit, U., Scott, M., and Cervone, D. (2019), “Automated Versus Do-It-Yourself Methods for Causal Inference: Lessons Learned from a Data Analysis Competition,” Statistical Science, 34, 43–68. DOI: 10.1214/18-STS667.
  • FDA. (2018), “Framework for FDA’s Real World Evidence Program.” Available at https://www.fda.gov/media/120060/download
  • FDA.(2021a), “Artificial Intelligence/Machine Learning (AI/ML)-based Software as a Medical Device (SaMD) Action Plan,” Available at https://www.fda.gov/media/145022/download.
  • FDA. (2021b), “Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision Making for Drug and Biological Products.” Available at https://www.fda.gov/media/152503/download.
  • Haibe-Kains, B., Adam, G. A., Hosny, A., Khodakarami, F., Waldron, L., Wang, B., McIntosh, C., Goldenberg, A., Kundaje, A., Greene, C. S., Broderick, T., Hoffman, M. M., Leek, J. T., Korthauer, K., Huber, W., Brazma, A., Pineau, J., Tibshirani, R., Hastie, T., Ioannidis, J. P. A., Quackenbush, J., and Aerts, H. J. W. L. (2020), “Transparency and Reproducibility in Artificial Intelligence,” Nature 586, E14–E16. DOI: 10.1038/s41586-020-2766-y.
  • Hastie, T., Tibshirani, R., and Friedman, J. (2009), “Unsupervised Learning,” in The Elements of Statistical Learning, pp. 485–585, New York: Springer.
  • Hernandez-Boussard, T., Blayney, D. W., and Brooks, J. D. (2020), “Leveraging Digital Data to Inform and Improve Quality Cancer Care,” Cancer Epidemiology and Prevention Biomarkers, 29, 816–822. DOI: 10.1158/1055-9965.EPI-19-0873.
  • Pham, P., Cheng, C., Wu, E., Kim, I., Zhang, R., Ma, Y., Kortepeter, C. M., and Muñoz, M. A. (2021), “Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports,” Pharmaceutical Medicine, 35, 307–316. DOI: 10.1007/s40290-021-00398-5.
  • Rudolph, K. E., and van der Laan, M. J. (2017), “Robust Estimation of Encouragement-Design Intervention Effects Transported Across Sites,” Journal of the Royal Statistical Society, Series B, 79, 1509–1525. DOI: 10.1111/rssb.12213.
  • Sharrar, R. G., and Dieck, G. S. (2013), “Monitoring Product Safety in the Postmarketing Environment,” Therapeutic Advances in Drug Safety, 4, 211–219. DOI: 10.1177/2042098613490780.
  • Shi, H., and Liu, Y. (2011), “Naïve Bayes vs. Support Vector Machine: Resilience to Missing Data,” in International Conference on Artificial Intelligence and Computational Intelligence, pp. 680–687, Springer.
  • Strobl, C., Malley, J., and Tutz, G. (2009), “An Introduction to Recursive Partitioning: Rationale, Application, and Characteristics of Classification and Regression Trees, Bagging, and Random Forests,” Psychological Methods, 14, 323–348. DOI: 10.1037/a0016973.
  • Van der Laan, M. J., and Rose, S. (2011), Targeted Learning: Causal Inference for Observational and Experimental Data, New York: Springer.
  • Wang, L. (2017), “Heterogeneous Data and Big Data Analytics,” Automatic Control and Information Sciences, 3, 8–15. DOI: 10.12691/acis-3-1-3.
  • Wunnava, S., Qin, X., Kakar, T., Socrates, V., Wallace, A., and Rundensteiner, E. (2017), “Towards Transforming FDA Adverse Event Narratives into Actionable Structured Data for Improved Pharmacovigilance,” in Proceedings of the Symposium on Applied Computing, pp. 777–782. DOI: 10.1145/3019612.3022875.
  • Zhou, Z.-H. (2021), “Ensemble Learning,” in Machine Learning, pp. 181–210, Singapore: Springer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.